NCT00146016View on ClinicalTrials.gov

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

January 31, 2007

Conditions
Chronic Hepatitis C
Interventions
DRUG

Amantadine

Trial Locations (1)

3508 GA

UMC Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT00146016 - Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients | Biotech Hunter | Biotech Hunter